Retention of hyaluronic acid in alginate beads: aspects for in vitro cartilage engineering.
Alginate has been used successfully for three-dimensional chondrocyte cultures and may be important for cartilage transplant formation. However, alginate is not a natural component of the cartilage matrix. The aim of this study was (a) to supplement alginate with the extracellular matrix component hyaluronic acid; and (b) to analyze the hyaluronic acid retention in different alginate gels. Hyaluronan is assumed to improve proteoglycan retention and may be important for in vitro matrix formation, tissue turgor, and biomechanical quality. Alginate and hyaluronan were mixed with chondrocytes and polymerized as were alginate, hyaluronan, and fibrinogen. [3H]hyaluronan was used to quantitate the leakage of hyaluronan from the gel beads. After 28 days in culture, 1.2% alginate beads supplemented with 0.26% hyaluronan contained only 9% of the initial amount of hyaluronan whereas 2.4% alginate beads still contained about 55% of the initial 0.22% hyaluronan. Release of hyaluronan from the beads was significantly lower if the beads additionally contained fibrin. Alginate beads supplemented with hyaluronan or fibrin showed increased chondrocyte proliferation compared to controls. Supplemented hyaluronan greatly diffuses out of alginate gels of lower densities. It must be assumed also that most of the hyaluronan newly synthesized by chondrocytes in these cells diffuses into the surrounding culture medium. The in vitro development of a sufficiently hygroscopic cartilage ground substance therefore may be very limited. Sufficient hyaluronic acid retention can be achieved in alginate gels with concentrations above 1.2% or by addition of fibrin.
Department of Orthopedics, Charité, Humboldt University of Berlin, Scharnhorststr. 3, 10115 Berlin, Germany. klaus.lindenhayn@charite.de
K
K
Lindenhayn
C
C
Perka
R
R
Spitzer
H
H
Heilmann
K
K
Pommerening
J
J
Mennicke
M
M
Sittinger
D000464:Alginates; D000818:Animals; D001672:Biocompatible Materials; D001698:Biomedical Engineering; D002358:Cartilage, Articular / Q000166:cytology* / Q000378:metabolism*; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000378:metabolism*; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D006820:Hyaluronic Acid; D066298:In Vitro Techniques; D008422:Materials Testing; D013552:Swine; D014316:Tritium
D000464:Alginates; D001672:Biocompatible Materials; D006603:Hexuronic Acids; D014316:Tritium; D020723:Glucuronic Acid; D006820:Hyaluronic Acid